The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ALLSCRIPTS HEALTHCARE SOLUTI | Equity | 01988P108 | 45,726 | 3,925,000 | SH | SOLE | 3,925,000 | 0 | 0 | ||
| AMGN US 07/19/19 P170 | Listed Option | 031162950 | 11 | 250 | SH | Put | SOLE | 250 | 0 | 0 | |
| ATRICURE INC | Equity | 04963C209 | 21,195 | 675,000 | SH | SOLE | 675,000 | 0 | 0 | ||
| BIO-RAD LABORATORIES-A | Equity | 090572207 | 30,931 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
| CANTEL MEDICAL CORP | Equity | 138098108 | 9,113 | 115,000 | SH | SOLE | 115,000 | 0 | 0 | ||
| CORREVIO PHARMA CORP | Equity | 22026V105 | 7,437 | 3,350,000 | SH | SOLE | 3,350,000 | 0 | 0 | ||
| HAEMONETICS CORP/MASS | Equity | 405024100 | 12,057 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
| HOLOGIC INC | Equity | 436440101 | 13,019 | 275,000 | SH | SOLE | 275,000 | 0 | 0 | ||
| IVERIC BIO INC | Equity | 46583P102 | 3,720 | 3,000,000 | SH | SOLE | 3,000,000 | 0 | 0 | ||
| LANTHEUS HOLDINGS INC | Equity | 516544103 | 20,104 | 730,000 | SH | SOLE | 730,000 | 0 | 0 | ||
| MEDTRONIC PLC | Equity | 585055106 | 41,168 | 420,000 | SH | SOLE | 420,000 | 0 | 0 | ||
| NEVRO CORP | Equity | 64157F103 | 3,154 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
| NOVOCURE LTD | Equity | G6674U908 | 9,636 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
| PACIRA BIOSCIENCES INC | Equity | 695127100 | 27,044 | 625,000 | SH | SOLE | 625,000 | 0 | 0 | ||
| PORTOLA PHARMACEUTICALS INC | Equity | 737010108 | 14,419 | 555,000 | SH | SOLE | 555,000 | 0 | 0 | ||
| QUEST DIAGNOSTICS INC | Equity | 74834L100 | 19,357 | 188,900 | SH | SOLE | 188,900 | 0 | 0 | ||
| RIGEL PHARMACEUTICALS INC | Equity | 766559603 | 14,016 | 5,475,000 | SH | SOLE | 5,475,000 | 0 | 0 | ||
| SPY US 07/19/19 P280 | Listed Option | 78462F953 | 24 | 2,000 | SH | Put | SOLE | 2,000 | 0 | 0 | |
| SPY US 07/19/19 P295 | Listed Option | 78462F953 | 240 | 2,000 | SH | Put | SOLE | 2,000 | 0 | 0 | |
| STERICYCLE INC | Equity | 858912108 | 22,373 | 475,000 | SH | SOLE | 475,000 | 0 | 0 | ||
| STREAMLINE HEALTH SOLUTIONS | Equity | 86323X106 | 3,276 | 2,100,000 | SH | SOLE | 2,100,000 | 0 | 0 | ||
| ZIMMER BIOMET HOLDINGS INC | Equity | 98956P102 | 10,863 | 90,000 | SH | SOLE | 90,000 | 0 | 0 | ||